Hairy cell leukemia is an uncommon hematologic malignancy that typically follows a slow course and requires specialized medical care. Treatment decisions are based on clinical findings and laboratory results unique to each patient. Sharing accurate, evidence-based information helps improve awareness and supports patients and caregivers in understanding this rare leukemia. https://www.oncoespecializados.com/medicamentos/cladribina-precio-mavenclad